Inhaled treprostinil solution

DRUG2 trials

Sponsors

United Therapeutics

Conditions

Chronic Obstructive Pulmonary DiseasePulmonary Hypertension

Phase 3

A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)

TerminatedNCT03496623

United TherapeuticsChronic Obstructive Pulmonary Disease, Pulmonary Hypertension

Start: 2018-05-08End: 2022-10-13Updated: 2023-11-24

Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

TerminatedNCT03794583

United TherapeuticsChronic Obstructive Pulmonary Disease, Pulmonary Hypertension

Start: 2018-12-21End: 2022-11-29Updated: 2026-05-27

Related Papers

Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results

European Respiratory Journal2024-05-2947 citations